Ann Marie Pendergast

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

A research team led by Ann Marie Pendergast, PhD, found, in animal studies, that a leukemia drug disrupted HER2-positive breast cancer-spread to the brain.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

DCI director Michael B. Kastan, MD, PhD, announced a planned reconfiguration of DCI’s NCI-Designated Research Programs and welcomed new research leaders.

A Duke research team has identified a molecular process by which lung cancer cells metastasize to the brain.

One top trainee from each of the eight DCI Research Programs presented their pioneering cancer research projects. Benjamin Mayro received the Bell Award.

In a new Cell Reports paper, DCI researchers report they've uncovered actionable targets for the treatment of brain metastases harboring lung adenocarcinoma.

Duke Cancer Institute hosted its Sixth Annual Scientific Retreat on Friday, October 25; attracting 166 DCI physicians, researchers, staff, and guests.

Dorothy Sipkins, MD, PhD, is developing a clinical trial of a new therapy that may force hidden breast cancer cells out of the bone marrow and back into the bloodstream.